% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Veltsista:277760,
author = {P. D. Veltsista and E. Oberacker and A. Ademaj and S.
Corradini and F. Eckert and A. Flörcken and D. Kaul$^*$ and
L. H. Lindner and R. Issels and O. J. Ott and D. Pink and V.
Potkrajcic and P. Reichardt and S. Roohani$^*$ and M. J.
Spalek and O. Riesterer and D. Zips$^*$ and P. Ghadjar},
title = {{H}yperthermia in the treatment of high-risk soft tissue
sarcomas: a systematic review.},
journal = {International journal of hyperthermia and thermal
therapies},
volume = {40},
number = {1},
issn = {0265-6736},
address = {London},
publisher = {Informa UK Limited},
reportid = {DKFZ-2023-01477},
pages = {2236337},
year = {2023},
abstract = {The therapy of high-risk soft tissue sarcomas (STS) remains
an interdisciplinary challenge. Regional hyperthermia (RHT)
sparked interest as it has been shown to improve overall
survival when added to perioperative chemotherapy (CTX).
However, questions arise on how RHT should be optimally
integrated into current multi-modal therapies.We performed a
systematic literature review according to Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines. Studies written in English and focused
mainly on radiative RHT and superficial hyperthermia were
evaluated and included. Studies including patients below the
age of 18, with metastatic disease or review articles, were
excluded.We identified 15 clinical reports from 1990 until
July 2022. Three articles combined RHT + CTX, and twelve
focused on combined RHT + radiotherapy (RT) or neoadjuvant
chemoradiotherapy (CRT). Most treatments were based on
invasive thermometry, and less on magnetic resonance imaging
(MRI)-based, noninvasive thermometry for STS of the
extremities. Perioperative chemotherapy was used for the
combination of RHT and CTX, mostly Ifosfamide-based. The
effectiveness of RT appeared to be increased by RHT,
especially with two RHT sessions/week. The trimodal
simultaneous approach of neoadjuvant RHT and CRT was also
feasible. No significant toxicity of RHT was reported.The
gathered data strengthen the beneficial role of RHT in the
multimodal setting. Further expert consensus and clinical
trials are required to determine the optimal integration of
RHT in treating STS.},
subtyp = {Review Article},
keywords = {Humans / Hyperthermia, Induced: methods / Antineoplastic
Combined Chemotherapy Protocols: therapeutic use / Sarcoma:
therapy / Ifosfamide: therapeutic use / Combined Modality
Therapy / Soft Tissue Neoplasms: drug therapy / Hyperthermia
(Other) / chemotherapy (Other) / high-risk (Other) /
radiation (Other) / sarcoma (Other) / Ifosfamide (NLM
Chemicals)},
cin = {BE01},
ddc = {610},
cid = {I:(DE-He78)BE01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37468132},
doi = {10.1080/02656736.2023.2236337},
url = {https://inrepo02.dkfz.de/record/277760},
}